332 related articles for article (PubMed ID: 28733131)
1. Preclinical studies for a phase 1 clinical trial of autologous hematopoietic stem cell gene therapy for sickle cell disease.
Urbinati F; Wherley J; Geiger S; Fernandez BC; Kaufman ML; Cooper A; Romero Z; Marchioni F; Reeves L; Read E; Nowicki B; Grassman E; Viswanathan S; Wang X; Hollis RP; Kohn DB
Cytotherapy; 2017 Sep; 19(9):1096-1112. PubMed ID: 28733131
[TBL] [Abstract][Full Text] [Related]
2. Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison Study.
Urbinati F; Campo Fernandez B; Masiuk KE; Poletti V; Hollis RP; Koziol C; Kaufman ML; Brown D; Mavilio F; Kohn DB
Hum Gene Ther; 2018 Oct; 29(10):1153-1166. PubMed ID: 30198339
[TBL] [Abstract][Full Text] [Related]
3. Enrichment of human hematopoietic stem/progenitor cells facilitates transduction for stem cell gene therapy.
Baldwin K; Urbinati F; Romero Z; Campo-Fernandez B; Kaufman ML; Cooper AR; Masiuk K; Hollis RP; Kohn DB
Stem Cells; 2015 May; 33(5):1532-42. PubMed ID: 25588820
[TBL] [Abstract][Full Text] [Related]
4. Preclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of β-thalassemia and sickle cell disease.
Negre O; Bartholomae C; Beuzard Y; Cavazzana M; Christiansen L; Courne C; Deichmann A; Denaro M; de Dreuzy E; Finer M; Fronza R; Gillet-Legrand B; Joubert C; Kutner R; Leboulch P; Maouche L; Paulard A; Pierciey FJ; Rothe M; Ryu B; Schmidt M; von Kalle C; Payen E; Veres G
Curr Gene Ther; 2015; 15(1):64-81. PubMed ID: 25429463
[TBL] [Abstract][Full Text] [Related]
5. Bone Marrow as a Hematopoietic Stem Cell Source for Gene Therapy in Sickle Cell Disease: Evidence from Rhesus and SCD Patients.
Uchida N; Fujita A; Hsieh MM; Bonifacino AC; Krouse AE; Metzger ME; Donahue RE; Tisdale JF
Hum Gene Ther Clin Dev; 2017 Sep; 28(3):136-144. PubMed ID: 28447889
[TBL] [Abstract][Full Text] [Related]
6. Potentially therapeutic levels of anti-sickling globin gene expression following lentivirus-mediated gene transfer in sickle cell disease bone marrow CD34+ cells.
Urbinati F; Hargrove PW; Geiger S; Romero Z; Wherley J; Kaufman ML; Hollis RP; Chambers CB; Persons DA; Kohn DB; Wilber A
Exp Hematol; 2015 May; 43(5):346-351. PubMed ID: 25681747
[TBL] [Abstract][Full Text] [Related]
7. Improved Titer and Gene Transfer by Lentiviral Vectors Using Novel, Small β-Globin Locus Control Region Elements.
Morgan RA; Unti MJ; Aleshe B; Brown D; Osborne KS; Koziol C; Ayoub PG; Smith OB; O'Brien R; Tam C; Miyahira E; Ruiz M; Quintos JP; Senadheera S; Hollis RP; Kohn DB
Mol Ther; 2020 Jan; 28(1):328-340. PubMed ID: 31628051
[TBL] [Abstract][Full Text] [Related]
8. Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein.
Di Nunzio F; Piovani B; Cosset FL; Mavilio F; Stornaiuolo A
Hum Gene Ther; 2007 Sep; 18(9):811-20. PubMed ID: 17824830
[TBL] [Abstract][Full Text] [Related]
9. Development of a forward-oriented therapeutic lentiviral vector for hemoglobin disorders.
Uchida N; Hsieh MM; Raines L; Haro-Mora JJ; Demirci S; Bonifacino AC; Krouse AE; Metzger ME; Donahue RE; Tisdale JF
Nat Commun; 2019 Oct; 10(1):4479. PubMed ID: 31578323
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of a tCD25 preselective combination anti-HIV lentiviral vector in human hematopoietic stem and progenitor cells.
Barclay SL; Yang Y; Zhang S; Fong R; Barraza A; Nolta JA; Torbett BE; Abedi M; Bauer G; Anderson JS
Stem Cells; 2015 Mar; 33(3):870-9. PubMed ID: 25524029
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E
Heffner GC; Bonner M; Christiansen L; Pierciey FJ; Campbell D; Smurnyy Y; Zhang W; Hamel A; Shaw S; Lewis G; Goss KA; Garijo O; Torbett BE; Horton H; Finer MH; Gregory PD; Veres G
Mol Ther; 2018 Jan; 26(1):320-328. PubMed ID: 29102562
[TBL] [Abstract][Full Text] [Related]
12. Advances in stem cell transplantation and gene therapy in the β-hemoglobinopathies.
Payen E; Leboulch P
Hematology Am Soc Hematol Educ Program; 2012; 2012():276-83. PubMed ID: 23233592
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders.
Persons DA
Hematology Am Soc Hematol Educ Program; 2009; ():690-7. PubMed ID: 20008255
[TBL] [Abstract][Full Text] [Related]
14. Gene Therapy Approaches to Hemoglobinopathies.
Ferrari G; Cavazzana M; Mavilio F
Hematol Oncol Clin North Am; 2017 Oct; 31(5):835-852. PubMed ID: 28895851
[TBL] [Abstract][Full Text] [Related]
15. Improving Gene Therapy Efficiency through the Enrichment of Human Hematopoietic Stem Cells.
Masiuk KE; Brown D; Laborada J; Hollis RP; Urbinati F; Kohn DB
Mol Ther; 2017 Sep; 25(9):2163-2175. PubMed ID: 28663101
[TBL] [Abstract][Full Text] [Related]
16. Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34
Río P; Navarro S; Guenechea G; Sánchez-Domínguez R; Lamana ML; Yañez R; Casado JA; Mehta PA; Pujol MR; Surrallés J; Charrier S; Galy A; Segovia JC; Díaz de Heredia C; Sevilla J; Bueren JA
Blood; 2017 Sep; 130(13):1535-1542. PubMed ID: 28801449
[TBL] [Abstract][Full Text] [Related]
17. Stem cell therapy for sickle cell disease: transplantation and gene therapy.
Walters MC
Hematology Am Soc Hematol Educ Program; 2005; ():66-73. PubMed ID: 16304361
[TBL] [Abstract][Full Text] [Related]
18. Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease.
Poletti V; Urbinati F; Charrier S; Corre G; Hollis RP; Campo Fernandez B; Martin S; Rothe M; Schambach A; Kohn DB; Mavilio F
Mol Ther Methods Clin Dev; 2018 Dec; 11():167-179. PubMed ID: 30533448
[TBL] [Abstract][Full Text] [Related]
19. Aberrant Clonal Hematopoiesis following Lentiviral Vector Transduction of HSPCs in a Rhesus Macaque.
Espinoza DA; Fan X; Yang D; Cordes SF; Truitt LL; Calvo KR; Yabe IM; Demirci S; Hope KJ; Hong SG; Krouse A; Metzger M; Bonifacino A; Lu R; Uchida N; Tisdale JF; Wu X; DeRavin SS; Malech HL; Donahue RE; Wu C; Dunbar CE
Mol Ther; 2019 Jun; 27(6):1074-1086. PubMed ID: 31023523
[TBL] [Abstract][Full Text] [Related]
20. Transduction of human CD34+ CD38- bone marrow and cord blood-derived SCID-repopulating cells with third-generation lentiviral vectors.
Guenechea G; Gan OI; Inamitsu T; Dorrell C; Pereira DS; Kelly M; Naldini L; Dick JE
Mol Ther; 2000 Jun; 1(6):566-73. PubMed ID: 10933981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
